Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes

NCT06833723 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
1000
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences